Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
about
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancerPancreatic cancer: Are "liquid biopsies" ready for prime-time?Biomarkers in pancreatic adenocarcinoma: current perspectivesThe Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome.Histone deacetylases, microRNA and leptin crosstalk in pancreatic cancer.Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societies.Leveraging premalignant biology for immune-based cancer prevention.Familial pancreatic cancer: Concept, management and issues.Pancreatic cancer screening in different risk individuals with family history of pancreatic cancer-a prospective cohort study in Taiwan.Surveillance for neoplasia in the pancreasPotential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer.Self-Reported Questionnaire Detects Family History of Cancer in a Pancreatic Cancer Screening ProgramAn improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.Dilemmas in the management of screen-detected lesions in patients at high risk for pancreatic cancerGermline mutations in pancreatic cancer and potential new therapeutic options.Nivolumab-induced aplastic anemia: A case report and literature review.[Early stage pancreatic cancer].Simple Detection of Telomere Fusions in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Cyst Fluid.Recent advances in the management of pancreatic adenocarcinoma.The importance of a well-structured pancreatic screening program for familial and hereditary pancreatic cancer.Development of a high risk pancreatic screening clinic using 3.0 T MRI.Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer.Feasibility of portal or superior mesenteric vein resection and reconstruction by allogeneic vein for pancreatic head cancer-a case-control study.Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges.Circulating Biomarkers to Identify Patients With Resectable Pancreatic Cancer.Pancreatic cancer screening.European evidence-based guidelines on pancreatic cystic neoplasms.Results of surveillance in individuals at high-risk of pancreatic cancer: A systematic review and meta-analysis.Germline Variants and Risk for Pancreatic Cancer: A Systematic Review and Emerging ConceptsFamilial pancreatic cancerIncidence of Pathogenic Variants in Those With a Family History of Pancreatic Cancer
P2860
Q28066320-C56897FD-7896-4FB5-A00F-90492C901E8FQ28068665-09271AFF-EFF4-490D-B44B-4F6DF222DE75Q28072309-F88DC090-4EB4-4201-A30E-7BA8A34A73F2Q33584095-C5833753-492D-4AEB-986C-887AED84F602Q33779854-65C0A6DB-4270-478A-906F-D577B0634D4AQ33840632-8B0DBAD2-FEF8-4B12-938D-698515BB0CF4Q37304964-1A0359BA-C270-45F1-A5D4-EAD7672A0E5BQ37644011-83D87391-C8D4-4614-A8B0-71F4B5B49DB8Q37680013-F1F9CA5E-692E-41F0-A569-3B4C85F18293Q38784725-FEC98B1A-9ACA-443A-AE01-4FD3E21D78A7Q38965713-E93AAFE5-2399-4135-870B-8DB145EED17CQ39048127-4274027F-15A2-4452-816C-55B101358D9CQ39425159-249DD28A-5CBE-48F2-B4D3-A71268ACAC3BQ42133274-3B7F9FAD-4139-4AE4-BE45-93958B6203B6Q42700671-B5A7715B-B049-41E4-B0A4-3474486B6895Q47663335-20A9469B-D8C5-446C-9AE8-55F26A5B299EQ49630827-41CC95F4-E87C-4D93-A7B4-A7FBF2796C38Q49923147-6ADC797D-741F-4A92-A9EC-0D4CFD3D3C84Q50072347-24E6922F-E0B2-4F89-8433-374C12281D93Q50075587-B00F125E-008C-4125-BD16-48362DE56A01Q50171374-BCB4ADB2-D133-412B-AC57-CF620B0C3529Q52579674-15203B59-7701-4104-A32E-AED207ADECE0Q52585092-6350BD68-5EED-4C32-AAB6-0C0EBC90C421Q52666355-6F03AD98-0C66-45B7-B132-786DF764A01BQ53739983-A07098EC-7C0A-4560-ADDA-D5D5C1E0D1E3Q54492414-50325F40-C2CC-4AC5-8ECE-2556D469ABBBQ54943890-FBADC283-9089-40C6-9D73-58322E288A62Q54981322-9287617F-6A33-46A1-962D-566C2ABBC667Q57165768-F8A22574-5617-4635-9AFB-25FD62DA0604Q57643835-E64C72BD-D4B6-4367-B64A-F00044752B09Q58729307-46C806C2-6D84-46AB-A7B2-238D31059473
P2860
Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Benefit of Surveillance for Pa ...... Three European Expert Centers.
@en
Benefit of Surveillance for Pa ...... Three European Expert Centers.
@nl
type
label
Benefit of Surveillance for Pa ...... Three European Expert Centers.
@en
Benefit of Surveillance for Pa ...... Three European Expert Centers.
@nl
prefLabel
Benefit of Surveillance for Pa ...... Three European Expert Centers.
@en
Benefit of Surveillance for Pa ...... Three European Expert Centers.
@nl
P2093
P50
P356
P1476
Benefit of Surveillance for Pa ...... Three European Expert Centers.
@en
P2093
Alfonso Sanjuanbenito
Alfredo Carrato
Anneke M van Mil
Bert A Bonsing
Christoph Schicker
Detlef K Bartsch
Elvira Matthäi
Emily P Slater
Evelina Mocci
Günter Klöppel
P304
P356
10.1200/JCO.2015.64.0730
P407
P577
2016-04-25T00:00:00Z